Viatrexx-Articula is a Intramuscular; Intravenous; Parenteral; Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Viatrexx Bio Incorporated. The primary component is Anti-interleukin-1.alpha. Immunoglobulin G Rabbit; Bos Taurus Ankle Joint; Sus Scrofa Ankle Joint; Metenkefalin; Ersofermin; Bos Taurus Achilles Tendon; Sus Scrofa Achilles Tendon; Bos Taurus Hip Joint; Sus Scrofa Hip Joint; Bos Taurus Knee Joint; Sus Scrofa Knee Joint; Beef Liver; Pork Liver; Transforming Growth Factor Beta-1; Avotermin.
Product ID | 73069-037_9eff0917-36c9-4fee-8799-233396692ca3 |
NDC | 73069-037 |
Product Type | Human Prescription Drug |
Proprietary Name | Viatrexx-Articula |
Generic Name | Anti-interleukin 1, Ankle Articulations, Beta Endorphin, Bfgf, Calcaneal Tendon, Hip Articulation, Knee Articulation, Liver, Transforming Growth Factor-1, Transforming Gf-beta |
Dosage Form | Injection |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS |
Marketing Start Date | 2019-03-29 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | VIATREXX BIO INCORPORATED |
Substance Name | ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT; BOS TAURUS ANKLE JOINT; SUS SCROFA ANKLE JOINT; METENKEFALIN; ERSOFERMIN; BOS TAURUS ACHILLES TENDON; SUS SCROFA ACHILLES TENDON; BOS TAURUS HIP JOINT; SUS SCROFA HIP JOINT; BOS TAURUS KNEE JOINT; SUS SCROFA KNEE JOINT; BEEF LIVER; PORK LIVER; TRANSFORMING GROWTH FACTOR BETA-1; AVOTERMIN |
Active Ingredient Strength | 201 [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL |
Pharm Classes | Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Meat Proteins [EXT] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-05-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-05 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-05 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-05 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-05 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-06 |
Ingredient | Strength |
---|---|
ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT | 201 [kp_C]/mL |
SPL SET ID: | 71f83e88-f486-4d6b-83e1-b7ddf6ddef65 |
Manufacturer | |
UNII | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
73069-037 | Viatrexx-Articula | Anti-Interleukin 1, Ankle Articulations, Beta Endorphin, bFGF, Calcaneal tendon, Hip Articulation, Knee Articulation, Liver, Transforming Growth Factor-1, Transforming GF-Beta |
73069-108 | Viatrexx-Derma | Anti-Interleukin 1, Ankle Articulations, Beta Endorphin, bFGF, Calcaneal tendon, Hip Articulation, Knee Articulation, Liver, Transforming Growth Factor-1, Transforming GF-Beta |
63776-189 | Viatrexx-GI | Anti-Interleukin 1, Ankle Articulations, Beta Endorphin, bFGF, Calcaneal tendon, Hip Articulation, Knee Articulation, Liver, Transforming Growth Factor-1, Transforming GF-Beta |